← 返回

Long-Term Survival Advantage of Reoperative Surgical Mitral Valve Replacement Over Transcatheter Mitral Valve-in-Valve: A Multicenter Cohort.

期刊: The Annals of thoracic surgery 日期: 2026-09-01 PMID: 41995635 浏览: 41
作者: Won, Bolling, Romano, Johnston, Ailawadi, Mehta, Baldridge, An, Kruse, Byrd, Green, Malaisrie
Won, Bolling, Romano, Johnston, Ailawadi, Mehta, Baldridge, An, Kruse, Byrd, Green, & Malaisrie (2026). Long-Term Survival Advantage of Reoperative Surgical Mitral Valve Replacement Over Transcatheter Mitral Valve-in-Valve: A Multicenter Cohort.. The Annals of thoracic surgery.
Won, Bolling, Romano, Johnston, Ailawadi, Mehta, et al. Long-Term Survival Advantage of Reoperative Surgical Mitral Valve Replacement Over Transcatheter Mitral Valve-in-Valve: A Multicenter Cohort.. The Annals of thoracic surgery. 2026; PMID: 41995635
Won, Bolling, Romano, et al. Long-Term Survival Advantage of Reoperative Surgical Mitral Valve Replacement Over Transcatheter Mitral Valve-in-Valve: A Multicenter Cohort.[J]. The Annals of thoracic surgery. 2026.
@article{won2026,
  author = {Won and Bolling and Romano and Johnston and Ailawadi and Mehta and Baldridge and An and Kruse and Byrd and Green and Malaisrie},
  title = {Long-Term Survival Advantage of Reoperative Surgical Mitral Valve Replacement Over Transcatheter Mitral Valve-in-Valve: A Multicenter Cohort.},
  journal = {The Annals of thoracic surgery},
  year = {2026},
  note = {PMID: 41995635},
}
TY  - JOUR
AU  - Won
AU  - Bolling
AU  - Romano
AU  - Johnston
AU  - Ailawadi
AU  - Mehta
AU  - Baldridge
AU  - An
AU  - Kruse
AU  - Byrd
AU  - Green
AU  - Malaisrie
TI  - Long-Term Survival Advantage of Reoperative Surgical Mitral Valve Replacement Over Transcatheter Mitral Valve-in-Valve: A Multicenter Cohort.
T2  - The Annals of thoracic surgery
PY  - 2026
AN  - PMID:41995635
ER  - 

摘要

Although transcatheter mitral valve-in-valve replacement (mViV) is safe, long-term outcomes compared with reoperative surgical mitral valve replacement (rSMVR) remains unknown. This study compared long-term outcomes between mViV and rSMVR in patients with failing mitral bioprostheses.

AI 智能解读

相关文献

返回分类: 心血管
已选择 0 篇文献